| Adverse Event | Relative Rate<br/>(by time) | Relative Rate<br/>(by dose) | Relative Rate<br/>(by person vaccinated) |
| --- | --: | --: | --: |
| Abnormal uterine bleeding (menstrual irregularity) | 4059 [1440.6-12878] p=0.0 <br/>2420 [809.38-6413.0] p=0.0| 1192 [673.95-2162.8] p=0.0<br/>738 [391.6-1584] p=0.0| 359 [261.1-506.8] p=0.0<br/>181 [131.1-255.1] p=0.0|
| Miscarriage | 169 [110.3-272.7] p=0.0 <br/>79 [49.0-136] p=0.0| 57 [44.3-74.7] p=0.0<br/>27 [20.2-36.5] p=0.0| 18 [15.7-21.2] p=0.0<br/>7 [6.1-8.4] p=0.0|
| Fetal chromosomal abnormalities |  p=0.00058 <br/> p=0.0048|  p=0.00058<br/> p=0.0048|  p=0.00058<br/> p=0.0048|
| Fetal malformation | 21 [10.0-31.0] p=1.9x10^-07^ <br/> p=0.20| 20 [7.67-31.0] p=1.9x10^-07^<br/> p=0.20| 16 [5.00-30.0] p=2.1x10^-06^<br/> p=0.20|
| Fetal cystic hygroma |  p=0.0024 <br/> p=0.020|  p=0.0024<br/> p=0.020|  p=0.0024<br/> p=0.020|
| Fetal cardiac disorders | 17 [8.00-27.0] p=2.6x10^-06^ <br/>10 [4.00-17.0] p=0.00058| 16 [6.00-26.0] p=2.6x10^-06^<br/>9 [3.0-16] p=0.00058| 13 [4.00-25.0] p=2.7x10^-05^<br/>7 [1.7-15] p=0.0047|
| Fetal arrhythmia |  p=0.020 <br/> p=0.088|  p=0.020<br/> p=0.088|  p=0.020<br/> p=0.088|
| Fetal cardiac arrest |  p=6.9x10^-07^ <br/> p=0.088|  p=6.9x10^-07^<br/> p=0.088|  p=6.9x10^-07^<br/> p=0.088|
| Fetal vascular mal-perfusion |  p=0.00015 <br/> p=0.020|  p=0.00015<br/> p=0.020|  p=0.00015<br/> p=0.020|
| Fetal growth abnormalities | 124 [40.75-210.0] p=0.0 <br/>42 [13.5-72.0] p=0.0| 56 [20.7-189] p=0.0<br/>22 [7.14-64.0] p=0.0| 15 [8.60-27.6] p=0.0<br/>5 [2.6-9.1] p=1.7x10^-08^|
| Fetal abnormal surveillance | 80 [26.1-192] p=0.0 <br/>66 [21.0-140] p=0.0| 25 [12.2-58.7] p=0.0<br/>24 [10.1-63.0] p=0.0| 7 [4.8-11] p=0.0<br/>5 [3.5-8.6] p=0.0|
| Fetal placental thrombosis |  p=0.0096 <br/> p=0.020|  p=0.0096<br/> p=0.020|  p=0.0096<br/> p=0.020|
| Fetal death (stillbirth) | 129 [46.75-409.0] p=0.0 <br/>79 [25.7-183] p=0.0| 38 [21.1-73.0] p=0.0<br/>26 [12.2-60.0] p=0.0| 11 [8.14-16.3] p=0.0<br/>6 [4.1-9.4] p=0.0|
